Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome (NCT06834594)
Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome: A Non-randomized Prospective Trial (The BOOST Study)
🩺 Plain-English Summary (8th-Grade Level)
This is a single-site open label non-randomized study comparing effects of sequential versus continuous use of progesterone supplementation amongst Turner Syndrome (TS) patients with primary ovarian insufficiency (POI) prescribed hormone replacement therapy (HRT).
Who can join: Review the eligibility criteria below.
Location: Children's Mercy Hospital — Kansas City, Missouri
Age range: 12 Years to 20 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Children's Mercy Hospital — Kansas City, Missouri
📞 Contact the Study Coordinator
Phone: (816) 394-7534
Email: alranallo@cmh.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Turner Syndrome
- A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome — Palo Alto, California
- Pre-pubertal Low Dose Transdermal Estradiol in Turner Syndrome — Washington D.C., District of Columbia
- UTHealth Turner Syndrome Research Registry — Houston, Texas
- Vosoritide for Short Stature in Turner Syndrome — Washington D.C., District of Columbia
- Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry — Aurora, Colorado
- Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders — Palo Alto, California
Explore by condition: All Turner Syndrome clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.